Nelson, Van Denburg & Campbell Wealth Management Group, LLC Crispr Therapeutics Ag Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.63 Billion
- Q4 2024
A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 30 shares of CRSP stock, worth $1,326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$1,326% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
485Shares Held
57.9MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$350 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$331 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$132 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$131 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$131 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.45B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....